187 related articles for article (PubMed ID: 33727810)
1. Formulation and Characterization of Phytostanol Ester Solid Lipid Nanoparticles for the Management of Hypercholesterolemia: An ex vivo Study.
Shrestha SC; Ghebremeskel K; White K; Minelli C; Tewfik I; Thapa P; Tewfik S
Int J Nanomedicine; 2021; 16():1977-1992. PubMed ID: 33727810
[TBL] [Abstract][Full Text] [Related]
2. Topical gel of Metformin solid lipid nanoparticles: A hopeful promise as a dermal delivery system.
Rostamkalaei SS; Akbari J; Saeedi M; Morteza-Semnani K; Nokhodchi A
Colloids Surf B Biointerfaces; 2019 Mar; 175():150-157. PubMed ID: 30530000
[TBL] [Abstract][Full Text] [Related]
3. Lipid-based nano-formulation platform for eplerenone oral delivery as a potential treatment of chronic central serous chorioretinopathy:
Abd-Elhakeem E; El-Nabarawi M; Shamma R
Drug Deliv; 2021 Dec; 28(1):642-654. PubMed ID: 33787445
[TBL] [Abstract][Full Text] [Related]
4. Curcumin-loaded solid lipid nanoparticles have prolonged in vitro antitumour activity, cellular uptake and improved in vivo bioavailability.
Sun J; Bi C; Chan HM; Sun S; Zhang Q; Zheng Y
Colloids Surf B Biointerfaces; 2013 Nov; 111():367-75. PubMed ID: 23856543
[TBL] [Abstract][Full Text] [Related]
5. Modulating Drug Release and Enhancing the Oral Bioavailability of Torcetrapib with Solid Lipid Dispersion Formulations.
Liu Y; Salituro GM; Lee KJ; Bak A; Leung DH
AAPS PharmSciTech; 2015 Oct; 16(5):1091-100. PubMed ID: 25690735
[TBL] [Abstract][Full Text] [Related]
6. Design and statistical modeling of mannose-decorated dapsone-containing nanoparticles as a strategy of targeting intestinal M-cells.
Vieira AC; Chaves LL; Pinheiro M; Ferreira D; Sarmento B; Reis S
Int J Nanomedicine; 2016; 11():2601-17. PubMed ID: 27354792
[TBL] [Abstract][Full Text] [Related]
7. A novel method to produce solid lipid nanoparticles using n-butanol as an additional co-surfactant according to the o/w microemulsion quenching technique.
Mojahedian MM; Daneshamouz S; Samani SM; Zargaran A
Chem Phys Lipids; 2013 Sep; 174():32-8. PubMed ID: 23743405
[TBL] [Abstract][Full Text] [Related]
8. Solid Lipid Nanoparticles Approach for Lymphatic Targeting Through Intraduodenal Delivery of Quetiapine Fumarate.
Yasir M; Gaur PK; Puri D; Shehkar P; Kumar SS
Curr Drug Deliv; 2018; 15(6):818-828. PubMed ID: 28545354
[TBL] [Abstract][Full Text] [Related]
9. Formulation, characterization, and in vitro/vivo studies of aclacinomycin A-loaded solid lipid nanoparticles.
Jia Y; Ji J; Wang F; Shi L; Yu J; Wang D
Drug Deliv; 2016 May; 23(4):1317-25. PubMed ID: 25371296
[TBL] [Abstract][Full Text] [Related]
10. Primary Studies on Construction and Evaluation of Ion-Sensitive in situ Gel Loaded with Paeonol-Solid Lipid Nanoparticles for Intranasal Drug Delivery.
Sun Y; Li L; Xie H; Wang Y; Gao S; Zhang L; Bo F; Yang S; Feng A
Int J Nanomedicine; 2020; 15():3137-3160. PubMed ID: 32440115
[TBL] [Abstract][Full Text] [Related]
11. Sucrose ester stabilized solid lipid nanoparticles and nanostructured lipid carriers. I. Effect of formulation variables on the physicochemical properties, drug release and stability of clotrimazole-loaded nanoparticles.
Das S; Ng WK; Tan RB
Nanotechnology; 2014 Mar; 25(10):105101. PubMed ID: 24531790
[TBL] [Abstract][Full Text] [Related]
12. Systematic Approach for the Formulation and Optimization of Solid Lipid Nanoparticles of Efavirenz by High Pressure Homogenization Using Design of Experiments for Brain Targeting and Enhanced Bioavailability.
Gupta S; Kesarla R; Chotai N; Misra A; Omri A
Biomed Res Int; 2017; 2017():5984014. PubMed ID: 28243600
[TBL] [Abstract][Full Text] [Related]
13. Self-Assembled Benznidazole-Loaded Cationic Nanoparticles Containing Cholesterol/Sialic Acid: Physicochemical Properties, In Vitro Drug Release and In Vitro Anticancer Efficacy.
Dos Santos-Silva AM; de Caland LB; do Nascimento EG; Oliveira ALCSL; de Araújo-Júnior RF; Cornélio AM; Fernandes-Pedrosa MF; da Silva-Júnior AA
Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31083590
[TBL] [Abstract][Full Text] [Related]
14. Formulation of acyclovir-loaded solid lipid nanoparticles: design, optimization, and
El-Gizawy SA; El-Maghraby GM; Hedaya AA
Pharm Dev Technol; 2019 Dec; 24(10):1287-1298. PubMed ID: 31507232
[TBL] [Abstract][Full Text] [Related]
15. Naringenin-loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and pulmonary pharmacokinetics.
Ji P; Yu T; Liu Y; Jiang J; Xu J; Zhao Y; Hao Y; Qiu Y; Zhao W; Wu C
Drug Des Devel Ther; 2016; 10():911-25. PubMed ID: 27041995
[TBL] [Abstract][Full Text] [Related]
16. Physicochemical characteristics, cytotoxicity, and antioxidant activity of three lipid nanoparticulate formulations of alpha-lipoic acid.
Ruktanonchai U; Bejrapha P; Sakulkhu U; Opanasopit P; Bunyapraphatsara N; Junyaprasert V; Puttipipatkhachorn S
AAPS PharmSciTech; 2009; 10(1):227-34. PubMed ID: 19280350
[TBL] [Abstract][Full Text] [Related]
17. Solid lipid nanoparticles as an efficient drug delivery system of olmesartan medoxomil for the treatment of hypertension.
Pandya NT; Jani P; Vanza J; Tandel H
Colloids Surf B Biointerfaces; 2018 May; 165():37-44. PubMed ID: 29453084
[TBL] [Abstract][Full Text] [Related]
18. Formulation design, characterization, and in vitro and in vivo evaluation of nanostructured lipid carriers containing a bile salt for oral delivery of gypenosides.
Yang G; Wu F; Chen M; Jin J; Wang R; Yuan Y
Int J Nanomedicine; 2019; 14():2267-2280. PubMed ID: 31015758
[TBL] [Abstract][Full Text] [Related]
19. Solid lipid nanoparticles as vesicles for oral delivery of olmesartan medoxomil: formulation, optimization and in vivo evaluation.
Nooli M; Chella N; Kulhari H; Shastri NR; Sistla R
Drug Dev Ind Pharm; 2017 Apr; 43(4):611-617. PubMed ID: 28005442
[TBL] [Abstract][Full Text] [Related]
20. [Study on preparation and characterization of resveratrol solid lipid nanoparticles and its anticancer effects in vitro].
Zhang QH; Xiong QP; Shi YY; Zhang DY
Zhong Yao Cai; 2010 Dec; 33(12):1929-32. PubMed ID: 21548373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
